Within the next few decades, the exponential growth of computer power will ensure every cubic metre of the planet is computationally accessible to remote monitoring, micro-management and control. Harnessed to biotechnology and nanorobotics, this growth in surveillance and control capabilities presents huge risks and huge opportunities. In a dystopian vein, such technologies lend themselves to advanced war-fighting. Or they could be used to sustain an Orwellian dictatorship. Alternatively, such technologies could deliver compassionate stewardship of the entire living world.
Launching our compassionate stewardship of the living world with free-living elephants might seem an arbitrary choice of species. Why choose elephants for a feasibility study? But from an ethical point of view, elephants are a prime candidate. With a brain weighing just over five kilograms, the African elephant has the largest mind/brain of any terrestrial vertebrate. On some fairly modest assumptions, elephants are among the most sentient nonhuman animals. All the technologies necessary for a comprehensive elephant healthcare program are available, in principle if not yet in practice. Nothing speculative, transhumanist, or even especially futuristic in the way of high technology need be invoked to lay out the foundations of an elephant welfare state, although software tools for efficient remote monitoring and tele-diagnostics need further development. Admittedly, free-living elephants offer a comparatively "easy" example of compassionate species care. Elephants are large, long-lived, "charismatic" and herbivorous. No seemingly irreconcilable interests are involved (e.g. lions versus zebras) in safeguarding their interests because mature elephants typically have no natural predators besides Homo sapiens. The limiting factor on elephant population size in the absence of human predation or artificial fertility regulation is inadequate nutrition.
What would be the financial cost, at contemporary prices, of cradle-to-the-grave healthcare and welfare provision for the entire population of free-living African elephants? The elephant population of the African continent currently stands at around 500,000. Elephant taxonomy is currently in flux; but the half-million figure includes what is commonly known as the savannah (or bush) elephant, Loxodonta africana, and the forest species of elephant, Loxodonta cyclotis. An annual cost of somewhere between two and three billion dollars seems plausible. Most of the same challenges and opportunities arise for securing the well-being of the Asian elephant, Elephas maximus. An estimated 40,000 Asian elephants are left in the wild. So the type of program sketched out below could be implemented at a fraction of the price.
Most human healthcare expenses are incurred in the last six months, and often the last six weeks, of life. In the case of elephants, we simply don't know the upper bounds to life-expectancy, given adequate late-life dentition. Assuming effective orthodontic care, this particular challenge, i.e. managing the age-related infirmities of free-living geriatric elephants, will (presumably) be decades away from the launch of an orthodontic healthcare service. After being GPS chipped, vaccinated and (where necessary) provided with immunocontraception, most free-living elephants could be remotely monitored but otherwise largely left in peace - apart from in years of drought and famine, when costly crisis-interventions will be necessary. To flourish, free-living elephants need a habitat that offers fresh water, plentiful vegetation for grazing and browsing; and some available shade. A mature African bush elephant typically ingests over 200 kilograms of vegetable matter daily. When needed, the cost of providing additional vaccinations, vitamin and mineral supplements, painkillers, anti-inflammatories, parasiticides, sedatives and anaesthetics, antibiotics, antifungals and antivirals, disinfectants and cleaning agents will not be negligible; but the relevant agents are almost all off-patent. Training and labour costs of ancillary support staff in sub-Saharan Africa are comparatively low; and likely to remain so for the foreseeable future. Close, politically sensitive collaboration with the local human populations will be vital to the long-term success of the project. Elephant healthcare work could provide valuable employment. Some forms of expertise could be delivered only by specialist veterinarians. An air-ambulance service would incur significant transport costs.
For now, financial projections of comprehensive free-living elephant care will depend on back-of-an-envelope calculations rather than a rigorous methodology. But a $2.5 billion annual price-tag of full healthcare and welfare provision for the entire population of free-living African elephants may turn out to be pessimistic. Financial planners will just need to bear in mind the potential for cost overruns and unexpected expenses that tend to plague any new enterprise. The likely extent of corruption, maladministration and the growth of a welfare bureaucracy in a elephant healthcare program are hard to quantify. In practice, the great majority of Africa's 500,000 elephant population would need far less than the annual $5000 per head this figure allows. Chipping, individual genome sequencing, vaccinations, GPS tracking and (when appropriate) immunocontraception would cost at most a few hundred dollars. The chipping, individual genome sequencing and vaccinations would typically be a one-off expense rather than a regular part of the annual budget. What's feasible at modest expense for e.g. all UK "domestic" dogs is no less feasible for free-living elephants. Chipping could range from simple tagging to more complex remote-monitoring of health status (e.g. cortisol monitoring. Elevated cortisol levels are suggestive of high stress and consequent need for investigation and possible compassionate intervention.)
What would be the timescale for complete coverage of Africa's elephant population? Perhaps one or two years - but only if an international consensus existed.
If we can underwrite the well-being of elephants, should we aim, ultimately, to extend our compassionate stewardship to the rest of the living world?